Valeant says may raise Allergan bid; beats on profit

Valeant Pharmaceuticals says it might up the ante in its hostile takeover bid for Allergan as it reports higher-than-forecast profits for its 3rd quarter.

Valeant Pharmaceuticals, Allergan Inc.

News Well, MassDevice.com Earnings Roundup, 2014, Mergers & Acquisitions, Pharmaceuticals, Q3

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vWeFhs